Placebo Discovery Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 13-12-2024
- Paid Up Capital ₹ 0.10 M
as on 13-12-2024
- Company Age 6 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 150.64%
(FY 2022)
- Profit 1.84%
(FY 2022)
- Ebitda 48.33%
(FY 2022)
- Net Worth 2.12%
(FY 2022)
- Total Assets 69.62%
(FY 2022)
About Placebo Discovery Life Sciences
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ankur Dubey and Sonam Dubey serve as directors at the Company.
- CIN/LLPIN
U51909UP2018PTC105782
- Company No.
105782
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jun 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Placebo Discovery Life Sciences Private Limited offer?
Placebo Discovery Life Sciences Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Nutritional Supplements, Pain Relief Drugs & Pharmaceuticals, Anti Inflammatory Drugs, Ayurvedic,Herbal Products & Medicine, Herbal Capsules, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Laxatives, Multivitamin Syrup & Drops.
Who are the key members and board of directors at Placebo Discovery Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ankur Dubey  | Director | 29-Jun-2018 | Current |
| Sonam Dubey | Director | 17-May-2024 | Current |
Financial Performance of Placebo Discovery Life Sciences.
Placebo Discovery Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 150.64% increase. The company also saw a slight improvement in profitability, with a 1.84% increase in profit. The company's net worth moved up by a moderate rise of 2.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Placebo Discovery Life Sciences?
Unlock access to Placebo Discovery Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Placebo Discovery Life Sciences?
Unlock and access historical data on people associated with Placebo Discovery Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Placebo Discovery Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Placebo Discovery Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
